Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Lymphoma × tafasitamab × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 1

Interventions

Gene Expression Profiling 10 Polymerase Chain Reaction 8 Amplified Fragment Length Polymorphism Analysis 8 Surveys and Questionnaires 7 Immunohistochemistry 7 Flow Cytometry 7 Microarray Analysis 6 Interviews as Topic 4 Rituximab 3 Psychiatric Rehabilitation 3 Immunologic Techniques 3 Gene Rearrangement 3 Data Collection 3 Cytogenetic Analysis 3 Biopsy 3 plerixafor 2 Therapeutics 2 Positron-Emission Tomography 2 Phlebotomy 2 Pharmacogenomic Testing 2 Observation 2 Mental Status and Dementia Tests 2 Magnetic Resonance Spectroscopy 2 Leukapheresis 2 Lenalidomide 2 In Situ Hybridization, Fluorescence 2 Hematologic Tests 2 Focus Groups 2 Drug Therapy 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04981795 2024-12-10

realMIND

Incyte Corporation

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡